Adaptive Biotechnologies Insider Sold Shares Worth $8,501,149, According to a Recent SEC Filing
Harlan S Robins, Chief Scientific Officer, on July 02, 2026, sold 386,240 shares in Adaptive Biotechnologies (ADPT) for $8,501,149. Following the Form 4 filing with the SEC, Robins has control over a total of 1,019,658 common shares of the company, with 1,019,658 shares held directly. SEC Filing:
Harlan S Robins, Chief Scientific Officer, on July 02, 2026, sold 386,240 shares in Adaptive Biotechnologies (ADPT) for $8,501,149.
Following the Form 4 filing with the SEC, Robins has control over a total of 1,019,658 common shares of the company, with 1,019,658 shares held directly.
SEC Filing: